Brief: Piramal Pharma Approves Sale Of Unit For 85 Million Rupees
22/07/2025 07:41
July 22 (Reuters) - Piramal Pharma Ltd PIRM.NS: BOARD APPROVES SALE OF UNIT FOR 85 MILLION RUPEES UNIT DECOMMISSIONED, CONTRIBUTED NIL TO TURNOVER Source text: ID:nBSE4nC3jR Further company coverage: PIRM.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Piramal Pharma (Mumbai)
See all newsBrief: Piramal Pharma (Mumbai) Says Commercial Arrangement With Bayer Pharmaceuticals To Expire On December 31, 2026
Brief: Piramal Pharma (Mumbai) Says Tax Authority Confirms Demand Of 40.6 Million Rupees And Imposes Equivalent Penalty
India's Piramal Pharma falls after US FDA observations at UK facility
Brief: Piramal Pharma Says US FDA Issues Form-483 With 7 Observations To Morpeth UK Facility
Brief: Piramal Pharma Approves Exercise Of Call Option For Acquisition Of Additional 41% Equity In Yapan Bio